Home / Import refusals / AEK-8639074-4/21/1

FDA Import Refusal AEK-8639074-4/21/1 — Actavis Laboratories FL Inc.

Actavis Laboratories FL Inc. — FEI 3003937607

The FDA refused shipment AEK-8639074-4/21/1 from Actavis Laboratories FL Inc. (United States) on January 19, 2021. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charge: 75

Refusal Details

Date
January 19, 2021
Country
United States
Product Category
Drugs and Biologics
Product Code
62GCA49 NAPROXEN (ANTI-INFLAMMATORY)
Charges
75

Recent inspections

  • 1279403 (NAI Fri Jul 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1077902 (NAI Wed Jan 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996475 (NAI Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783945 (NAI Fri Apr 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources